• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临终关怀项目注册患者处方的传真传输。美国缉毒局(DEA),司法部。最终规则。

Facsimile transmission of prescriptions for patients enrolled in hospice programs. Drug Enforcement Administration (DEA), Justice. Final rule.

出版信息

Fed Regist. 2001 Jan 11;66(8):2214-5.

PMID:11503757
Abstract

DEA is finalizing, without change, the interim rule with request for comment published in the Federal Register on July 25, 2000 (65 FR 45712). The interim rule amended Title 21, Code of Federal Regulations (CFR) 1306.11(g) to clearly articulate that prescriptions for Schedule II narcotic substances for patients enrolled in hospice care certified by Medicare under Title XVIII or licensed by the state may be transmitted by facsimile. No comments to the interim rule were received. This final rule makes the clarification permanent.

摘要

美国药品管理局(DEA)正在最终确定2000年7月25日在《联邦公报》(65 FR 45712)上发布的征求意见临时规则,且不作任何修改。该临时规则修订了《联邦法规汇编》(CFR)第21编第1306.11(g)条,以明确阐明,对于根据第十八编由医疗保险认证或由州颁发执照的临终关怀机构的患者,第二类麻醉药品的处方可以通过传真传输。未收到对该临时规则的任何评论。本最终规则使该澄清成为永久性规定。

相似文献

1
Facsimile transmission of prescriptions for patients enrolled in hospice programs. Drug Enforcement Administration (DEA), Justice. Final rule.临终关怀项目注册患者处方的传真传输。美国缉毒局(DEA),司法部。最终规则。
Fed Regist. 2001 Jan 11;66(8):2214-5.
2
Prescriptions; requirements clarification--Drug Enforcement Administration (DEA). Final rule.
Fed Regist. 1991 Jun 3;56(106):25025-7.
3
Control of a chemical precursor used in the illicit manufacture of fentanyl as a List I chemical. Final rule.将用作表一化学品的芬太尼非法制造中使用的一种化学前体的管制。最终规则。
Fed Regist. 2008 Jul 25;73(144):43355-7.
4
Prescriptions; dispensing controlled substances in institutional practitioner emergency rooms--Drug Enforcement Administration, Justice. Withdrawal of proposed rule.
Fed Regist. 1983 Jun 28;48(125):29713-4.
5
Elimination of exemptions for chemical mixtures containing the list I chemicals ephedrine and/or pseudoephedrine. Final rule.取消含有附表一化学品麻黄碱和/或伪麻黄碱的化学混合物的豁免规定。最终规则。
Fed Regist. 2008 Jul 10;73(133):39611-4.
6
Medicare and Medicaid programs; programs of all-inclusive care for the elderly (PACE); program revisions. Final rule.医疗保险和医疗补助计划;老年人全面护理计划(PACE);计划修订。最终规则。
Fed Regist. 2006 Dec 8;71(236):71243-337.
7
Changes to patient limitation for dispensing or prescribing approved narcotic controlled substances for maintenance or detoxification treatment by qualified individual practitioners. Final rule.
Fed Regist. 2008 May 22;73(100):29685-8.
8
Issuance of multiple prescriptions for schedule II controlled substances. Final rule.开具第二类管制物质的多张处方。最终规则。
Fed Regist. 2007 Nov 19;72(222):64921-30.
9
Schedules of controlled substances: rescheduling of buprenorphine from schedule V to schedule III. Final rule.管制物质清单:丁丙诺啡从V类重新划分为III类。最终规则。
Fed Regist. 2002 Oct 7;67(194):62354-70.
10
Medicare program; Medicare secondary payer (MSP) amendments. final rule.医疗保险计划;医疗保险第二支付方(MSP)修正案。最终规则。
Fed Regist. 2008 Feb 22;73(36):9679-85.